Therapy News and Research

RSS

In utero brain overgrowth linked to severity of autism

Some children with autism experience profound, lifelong difficulties like developmental delay, social struggles and even the inability to speak.

5 Jun 2024

New bilateral gene therapy shows promising results in treating genetic hearing loss

A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were treated in both ears.

5 Jun 2024

Emerging strains of resistant ringworm pose new public health threats in the U.S.

Healthcare providers should watch out for new and highly contagious forms of ringworm or jock itch, which are emerging as a potential public health threat, according to a pair of reports.

5 Jun 2024

JUN protein could slow prostate cancer growth, study finds

As prostate cancer progresses, it becomes increasingly aggressive and can metastasise. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate is the second most common cause of cancer death in men.

5 Jun 2024

US study finds girls are starting their periods earlier and taking longer to become regular

Researchers examined the temporal trends and inequalities in menstruation onset, time to regularity, and the role of early-life BMI as a mediator.

5 Jun 2024

Common anti-inflammatory drug could combat deadly gut fungus, study finds

A team of UC Davis Health researchers discovered that a common anti-inflammatory drug, mesalamine, can replace the work of good bacteria in fighting the nasty fungus Candida albicans in the gut.

4 Jun 2024

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma.

4 Jun 2024

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.

4 Jun 2024

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

A new study to be presented at the SLEEP 2024 annual meeting is the first to find that episodic hypoxemia and hypoxic burden related to obstructive sleep apnea are associated with the risk of accelerated lung cancer reoccurrence.

4 Jun 2024

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or metastatic non-small cell lung cancer with EGFR gene mutations who also present one of these poor prognosti markers: brain and/or liver metastases, p53 gene co-mutations, or the presence of circulating tumor DNA.

4 Jun 2024

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues.

4 Jun 2024

Applied Cells releases game-changing reagent kits to empower cell therapy development

Applied Cells is excited to announce the launch of its MARS® Ingenuity™ Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimized for use on Applied Cells’ proprietary MARS® Bar platform.

From Applied Cells 4 Jun 2024

Study: Fewer than one-quarter of heart attack patients receive dietary counseling in the aftermath

Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds.

4 Jun 2024

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells.

From Fluidic Sciences and Sphere Bio 4 Jun 2024

Digital pregnancy support app predicts future depression with high accuracy

A simple survey delivered during the first trimester through digital pregnancy support app MyHealthyPregnancy predicted which mothers went on to develop moderate to severe depression with a high level of accuracy, according to a new Archives of Women's Mental Health study led by University of Pittsburgh and UPMC researchers.

3 Jun 2024

Study: One out of five breast cancer survivors may experience weight gain

Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass., and published in the journal Thyroid.

3 Jun 2024

Vasomotor symptoms in menopausal women linked to greater risk for non-alcoholic fatty liver disease

Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33

The effects of statins via inhibition of interleukin 33 (IL-33).

3 Jun 2024

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.

3 Jun 2024

Therapy News and Research

In utero brain overgrowth linked to severity of autism

New bilateral gene therapy shows promising results in treating genetic hearing loss

Emerging strains of resistant ringworm pose new public health threats in the U.S.

JUN protein could slow prostate cancer growth, study finds

US study finds girls are starting their periods earlier and taking longer to become regular

Common anti-inflammatory drug could combat deadly gut fungus, study finds

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

Applied Cells releases game-changing reagent kits to empower cell therapy development

Study: Fewer than one-quarter of heart attack patients receive dietary counseling in the aftermath

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Digital pregnancy support app predicts future depression with high accuracy

Study: One out of five breast cancer survivors may experience weight gain

Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab

Vasomotor symptoms in menopausal women linked to greater risk for non-alcoholic fatty liver disease

Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News